Psy 232 GF08 Experimental Designs:
Between Groups
Scores from
separate groups of individuals are compared
Step 1: A sample of participants is selected from the
population
NOTE regarding
N: sample should be sufficiently
large, so that when
groups are formed you’ll have 30+
per group if possible
The CLT
(ensures normality assumption) applies to your
groups,
not
to the overall sample!
Step 2: Participants assigned to different groups (i.e., to
different “treatments”)
Step 3: Scores from the treatment groups are collected.
Step 4: Scores are analyzed via appropriate statistics tests.
Note: A between-groups design allows only one score per person.
Thus # scores = # participants.
Advantages of
independent-measures designs
NOTE: ‘independence’
à
random assignment & other methodological steps to ensure it.
Scores are independent of one another, since each participant is
measured
only once in only one treatment.
That is, carry-over effects from one tx to another one are eliminated.
Fatigue effects from participating in a series of treatments are
eliminated.
Contrast effects between treatments are eliminated
These designs can be used in almost all research situations
(although
they aren’t always the best ones)
Disadvantages of
independent-measures designs
Primary problem – large individual differences
Can become confounding variables [Examples . . .]
Can produce high variability in the scores, thus obscuring effects of treatments
In t-test, this would increase sM, thus
causing “chance” to be larger.
Other problem – large # of participants are needed
Increases testing-time and related hassles for the
researcher
May be difficult to find participants when studying special
populations
Eliminating
confounding variables
Process for selecting participants should be similar for all groups
All aspects of participants’ experiences should be the same,
except for experimental manipulation.
Participants should be similar across all groups.
Primary technique: random assignment of participants to
groups.
Note: this can be restricted as needed to ensure
equal #’s per group.
Note: this works particularly well with large n’s,
but less well with small n’s
Additional techniques:
Matching participants on particular vars to ensure similarity across groups
This requires prior measurement of the variable of
interest
May be costly or tedious process
May be difficult to accomplish when more than one
variable is of concern
Holding a variable constant, or else restricting its
range of variation
Advantage – ensures that participants are similar on
the var of concern.
Disadvantage –limits external validity since
generalization is limited.
Most of the time: when possible, go with larger n’s and
use random assignment.
Managing effects of
high variability
Remember that stats tests typically compare treatment-effects to
chance-effects
If the treatment-effects = chance-effects, then we say that the tx did
not work.
If the treatment-effects ≠ chance-effects, then we say that the
treatment did work.
Thus we usually want to increase treatment-effects and to minimize
chance-effects.
Chance-effects are due to differences within groups (i.e., sM).
Since individual diffs are part of “chance,” we reduce them as much as
possible.
Techniques for reducing the effects of individual differences:
Standardize research materials procedures.
[Examples . . .]
Standardize research settings.
[Examples . . .]
Hold a participant variable constant.
[Examples . . .]
Increase sample size. [Examples . .
.]
Note: this doesn’t reduce individual diffs, but it does reduce their effect.
See t-test formula for reminder of
why this is true
Typical designs
Two-group design – One IV with two levels: often a “treatment” versus a
“control”
Advantage 1: Simple to set up and carry out
Advantage 2: Useful for comparing extreme values of an IV (e.g.
zero versus max).
Disadvantage 1: Provides info about only two pts, so rel betw DV & IV
is unclear.
[Examples: when the relation for all values is
curvilinear . . .]
Disadvantage 2: More than one control is often needed . . .
[Examples: “no-treatment” versus “placebo” versus treatment . . .]
Multi-group design – One IV with three or more levels (treatments)
Multiple control groups are possible.
[Examples . . .]
Multiple treatment groups are possible.
[Examples . . .]
Gives a clearer picture of the overall rel between the DV and IV
[Examples . . .]
Minor caution: using too many groups may cause some
analysis problems.